Nf1 and Gmcsf interact in myeloid leukemogenesis

被引:111
作者
Birnbaum, RA
O'Marcaigh, A
Wardak, Z
Zhang, YY
Dranoff, G
Jacks, T
Clapp, DW
Shannon, KM [1 ]
机构
[1] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA
[2] Indiana Univ, Sch Med, Dept Pediat, Indianapolis, IN 46202 USA
[3] Indiana Univ, Sch Med, Herman B Wells Ctr, Indianapolis, IN 46202 USA
[4] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA
[5] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA
关键词
D O I
10.1016/S1097-2765(00)80415-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The NF1 tumor suppressor gene encodes neurofibromin, a GTPase-activating protein (GAP) for p21(ras) (Ras). Children with NF1 are predisposed to juvenile myelomonocytic leukemia (JMML). Some heterozygous Nf1 mutant mice develop a similar myeloproliferative disorder (MPD), and adoptive transfer of Nf1-deficient fetal liver cells consistently induces this MPD. Human JMML and murine Nf1-deficient cells are hypersensitive to granulocyte-macrophage colony-stimulating factor (GM-CSF) in methylcellulose cultures. We generated hematopoietic cells deficient in both Nf1 and Gmcsf to test whether GM-CSF is required to drive excessive proliferation of Nf1(-/-) cells in vivo. Here we show that GM-CSF plays a central role in establishing and maintaining the MPD and that recipients engrafted with Nf1(-/-) Gmcsf(-/-) hematopoietic cells are hypersensitive to exogenous GM-CSF.
引用
收藏
页码:189 / 195
页数:7
相关论文
共 40 条
  • [1] Juvenile myelomonocytic leukemia
    Arico, M
    Biondi, A
    Pui, CH
    [J]. BLOOD, 1997, 90 (02) : 479 - 488
  • [2] The structural and functional basis of cytokine receptor activation: Lessons from the common beta subunit of the granulocyte-macrophage colony-stimulating factor, interleukin-3 (IL-3), and IL-5 receptors
    Bagley, CJ
    Woodcock, JM
    Stomski, FC
    Lopez, AF
    [J]. BLOOD, 1997, 89 (05) : 1471 - 1482
  • [3] NEUROFIBROMATOSIS TYPE-1 AND RAS-MEDIATED SIGNALING - FILLING IN THE GAPS
    BERNARDS, A
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1995, 1242 (01): : 43 - 59
  • [4] PROTEINS REGULATING RAS AND ITS RELATIVES
    BOGUSKI, MS
    MCCORMICK, F
    [J]. NATURE, 1993, 366 (6456) : 643 - 654
  • [5] Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells
    Bollag, G
    Clapp, DW
    Shih, S
    Adler, F
    Zhang, YY
    Thompson, P
    Lange, BJ
    Freedman, MH
    McCormick, F
    Jacks, T
    Shannon, K
    [J]. NATURE GENETICS, 1996, 12 (02) : 144 - 148
  • [6] BOS JL, 1989, CANCER RES, V49, P4682
  • [7] THE GTPASE SUPERFAMILY - A CONSERVED SWITCH FOR DIVERSE CELL FUNCTIONS
    BOURNE, HR
    SANDERS, DA
    MCCORMICK, F
    [J]. NATURE, 1990, 348 (6297) : 125 - 132
  • [8] TARGETED DISRUPTION OF THE NEUROFIBROMATOSIS TYPE-1 GENE LEADS TO DEVELOPMENTAL ABNORMALITIES IN HEART AND VARIOUS NEURAL CREST-DERIVED TISSUES
    BRANNAN, CI
    PERKINS, AS
    VOGEL, KS
    RATNER, N
    NORDLUND, ML
    REID, SW
    BUCHBERG, AM
    JENKINS, NA
    PARADA, LF
    COPELAND, NG
    [J]. GENES & DEVELOPMENT, 1994, 8 (09) : 1019 - 1029
  • [9] Essential role for oncogenic Ras in tumour maintenance
    Chin, L
    Tam, A
    Pomerantz, J
    Wong, M
    Holash, J
    Bardeesy, N
    Shen, Q
    O'Hagan, R
    Pantginis, J
    Zhou, H
    Horner, JW
    Cordon-Cardo, C
    Yancopoulos, GD
    DePinho, RA
    [J]. NATURE, 1999, 400 (6743) : 468 - 472
  • [10] Dysregulated hematopoiesis and a progressive neurological disorder induced by expression of an activated form of the human common β chain in transgenic mice
    D'Andrea, RJ
    Harrison-Findik, D
    Butcher, CM
    Finnie, J
    Blumbergs, P
    Bartley, P
    McCormack, M
    Jones, K
    Rowland, R
    Gonda, TJ
    Vadas, MA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (11) : 1951 - 1960